Low Level Laser Therapy Versus Pharmacotherapy in Improving Myofascial Pain Disorder Syndrome
Khalighi HR, Mortazavi H, Mojahedi SM, Azari-Marhabi S, Moradi Abbasabadi F
Journal of lasers in medical sciences · 36 citas
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (clasificado por nuestro filtro de IA)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
- Universidad u hospital
- Shahid Beheshti University of Medical Sciences
Según 1 financiador declarado.
Publicación
- Publicado
- 2016-01-07 · J Lasers Med Sci · vol. 7 · número 1 · págs. 45–50
- Citado
- 118 citas · más que el 98% de estudios similares · 8.5× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 29 trabajos
- Acceso
- Acceso abierto (publicación gratuita) · CC-BY-NC
- Áreas de investigación
- Temporomandibular Joint Disorders · Laser Applications in Dentistry and Medicine · Myofascial pain diagnosis and treatment
- Palabras clave
- Medicine, Low level laser therapy, Visual analogue scale, Placebo, Burning mouth syndrome, Pharmacotherapy, Anesthesia, Randomized controlled trial, Physical therapy, Laser therapy, Internal medicine, Laser
5 autores
- Hamid Reza Khalighi🇮🇷Shahid Beheshti University of Medical Sciences
- Hamed Mortazavi🇮🇷Shahid Beheshti University of Medical Sciences
- Seyed Masoud Mojahedi🇮🇷Shahid Beheshti University of Medical Sciences
- Saranaz Azari-Marhabi🇮🇷Shahid Beheshti University of Medical Sciences
- Faranak Moradi Abbasabadi🇮🇷Qom University of Medical Science and Health Services
Resumen
El texto original del estudio, en el idioma en que se publicó.
Introduction
Temporomandibular disorders (TMD) lead to masticatory muscle pain, jaw movement disability and limitation in mouth opening. Pain is the chief complaint in 90% of the TMD patients which leads to disability and severe socioeconomic costs. The purpose of this study was to evaluate the therapeutic effects of low level laser therapy (LLLT) compared to pharmacotherapy with NSAIDs (naproxen) in myofascial pain disorder syndrome (MPDS).
Methods
In this randomized controlled clinical trial, 40 MPDS patients were divided into two groups. One group received naproxen 500 mg bid for 3 weeks as treatment modality and also had placebo laser sessions. The other group received active laser (diode 810 nm CW) as treatment and placebo drug. Pain intensity was measured by visual analogue scale (VAS) and maximum painless mouth opening was also measured as a functional index every session and at 2 months follow up. Data was collected and analyzed with SPSS software. Independent t test was used to analyze the data. A P < 0.05 was considered significant.
Results
Low level laser caused significant reduction in pain intensity (P < 0.05) and a significant increase in mouth opening. In naproxen group neither pain intensity nor maximum mouth opening had significant improvement. Pain relief, in subjective VAS was observed in third session in LLLT group, but did not occur in naproxen group. Maximum mouth opening increased significantly in laser group compared to the naproxen group from the eighth session.
Conclusion
Treatment with LLLT caused a significant improvement in mouth opening and pain intensity in patients with MPDS. Similar improvement was not observed in naproxen group.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.